These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38150386)

  • 1. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators.
    Dubinsky M; Rice A; Yarlas A; Hur P; Cappelleri JC; Kulisek N; Fahrny A; Bushmakin A; Biedermann L
    Inflamm Bowel Dis; 2023 Dec; ():. PubMed ID: 38150386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of biological interventions for ulcerative colitis on health-related quality of life.
    LeBlanc K; Mosli MH; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD008655. PubMed ID: 26393522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Yarlas A; Maher S; Bayliss M; Lovley A; Cappelleri JC; Bushmakin AG; DiBonaventura MD
    J Patient Cent Res Rev; 2020; 7(2):189-205. PubMed ID: 32377552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.
    Armuzzi A; Rubin DT; Schreiber S; Panés J; Fellmann M; Bartolome L; Gruben D; Goetsch M; Bhattacharjee A; Chaparro M; Dubinsky MC
    Inflamm Bowel Dis; 2024 Sep; ():. PubMed ID: 39326009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis.
    Estevinho MM; Afonso J; Rosa I; Lago P; Trindade E; Correia L; Dias CC; Magro F;
    J Crohns Colitis; 2018 Nov; 12(10):1232-1244. PubMed ID: 30010736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of the Urgency NRS as a new patient-reported outcome measure for patients with ulcerative colitis.
    Dubinsky MC; Shan M; Delbecque L; Lissoos T; Hunter T; Harding G; Stassek L; Andrae D; Lewis JD
    J Patient Rep Outcomes; 2022 Nov; 6(1):114. PubMed ID: 36334163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain.
    Targownik L; Dubinsky MC; Steinwurz F; Bushmakin AG; Cappelleri JC; Tai E; Gardiner S; Hur P; Panés J
    J Crohns Colitis; 2023 Apr; 17(4):513-523. PubMed ID: 36271912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shortened questionnaire on quality of life for inflammatory bowel disease.
    Alcalá MJ; Casellas F; Fontanet G; Prieto L; Malagelada JR
    Inflamm Bowel Dis; 2004 Jul; 10(4):383-91. PubMed ID: 15475746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire.
    Casellas F; Alcalá MJ; Prieto L; Miró JR; Malagelada JR
    Am J Gastroenterol; 2004 Mar; 99(3):457-61. PubMed ID: 15056085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease.
    Ren WH; Lai M; Chen Y; Irvine EJ; Zhou YX
    Inflamm Bowel Dis; 2007 Jul; 13(7):903-10. PubMed ID: 17309070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
    Feagan BG; Patel H; Colombel JF; Rubin DT; James A; Mody R; Lasch K
    Aliment Pharmacol Ther; 2017 Jan; 45(2):264-275. PubMed ID: 27859410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece.
    Gatopoulou A; Christodoulou DK; Katsanos KH; Bakos D; Mouzas I; Tzouvala M; Theodoropoulou A; Paspatis G; Theocharis G; Thomopoulos K; Giouleme O; Kourikou A; Manolakopoulos S; Zampeli E; Michopoulos S; Karatzas P; Katsaros M; Moschovis D; Orfanoudaki E; Livieratos A; Petrikkou E; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e615-e624. PubMed ID: 34034278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease(IBDQ-32)].
    Masachs M; Casellas F; Malagelada JR
    Rev Esp Enferm Dig; 2007 Sep; 99(9):511-9. PubMed ID: 18052646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.
    Paschos P; Katsoula A; Salanti G; Giouleme O; Athanasiadou E; Tsapas A
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1174-1185. PubMed ID: 30378141
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.